Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
6.33
-0.53 (-7.73%)
At close: Nov 20, 2026, 4:00 PM EST
6.39
+0.06 (0.95%)
After-hours: Nov 20, 2026, 7:30 PM EST
Verastem Market Cap
Verastem has a market cap or net worth of $797.67 million as of November 20, 2026. It is the 10,757th most valuable company in the world and the 2,314th biggest in the United States. Its market cap has increased by 11.49% in one year.
Market Cap
797.67M
Enterprise Value
753.43M
1-Year Change
11.49%
Global Rank
Country Rank
#2,314 United States
Category
ChartMarket Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $224.40M to $797.67M, an increase of 255.48%. That is a compound annual growth rate of 8.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 797.67M | 33.87% |
| Dec 31, 2025 | 595.84M | 158.95% |
| Dec 31, 2024 | 230.10M | 11.87% |
| Dec 29, 2023 | 205.68M | 143.23% |
| Dec 30, 2022 | 84.56M | -77.36% |
| Dec 31, 2021 | 373.48M | 3.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 915.08M |
| City Therapeutics | 913.04M |
| Immatics | 905.99M |
| Odyssey Therapeutics | 879.24M |
| Latigo Biotherapeutics | 877.80M |
| Pharming Group | 844.83M |
| Corvus Pharmaceuticals | 844.37M |
| Inventiva | 835.32M |